Desperation showing again. I wonder if somehow word has leaked out from a clinical trial, or maybe someone at a big pharma has disclosed information that they learned after signing a Non-Disclosure Agreement which was supposed to prevent info leakage.

Because the load of BS has gotten surprisingly high.

Anyone who thinks that a market cap of about 150 million is too high for a company with 5 clinical trials, involving 3 different drugs, for 5 different applications -- well, clearly that person is either very ignorant, or has an ulterior motive. Does anyone really think that that a company trying to find a better drug for h. pylori (the cause of stomach ulcers, which are already treatable with a cocktail of existing antibiotics) and Crohn's Disease (an unmet need -- but not an extremely common disease) should be valued more than CTIX, with its 5 clinical trials and 3 completely different drugs -- those clinical trials being for much more common diseases or treatment of a debilitating side effect of cancer treatment (Brilacidin-Oral Mucositis)?

Nonsensical comparisons and claims that CTIX is overvalued should be seen as what they are -- desperate acts of people who want to suppress the stock price. Whatever their reasons, it really is a waste of time and their employers' resources to keep posting nonsense here. Surely even the newest readers must recognize the foolishness of these attempts to bash the stock.